The trend toward digitisation of clinical trials and the myriad benefits that partial or full decentralisation can offer has been proven to reduce costs, shorten the time to market for new therapies and improve ROI. The questions of digitisation’s impact on drug development are arguably answered, and whilst this has … Continue reading Video-Based Assessments to Digitise COA: the story of SARAhome